Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pesticides | 8 | 2024 | 296 | 5.120 |
Why?
|
Oxidative Stress | 34 | 2024 | 3141 | 2.890 |
Why?
|
Breast Neoplasms | 45 | 2024 | 21056 | 2.880 |
Why?
|
Nitric Oxide | 26 | 2024 | 2143 | 1.430 |
Why?
|
Glutathione Transferase | 2 | 2021 | 562 | 1.210 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 2 | 2020 | 283 | 1.200 |
Why?
|
Brazil | 9 | 2024 | 1248 | 1.090 |
Why?
|
Occupational Exposure | 4 | 2024 | 1805 | 1.030 |
Why?
|
Oxidation-Reduction | 11 | 2024 | 2218 | 1.000 |
Why?
|
Arachidonate 5-Lipoxygenase | 2 | 2019 | 128 | 0.970 |
Why?
|
Carcinoma, Ductal, Breast | 6 | 2021 | 1083 | 0.960 |
Why?
|
Lipid Peroxidation | 16 | 2024 | 275 | 0.920 |
Why?
|
Glucuronosyltransferase | 1 | 2024 | 136 | 0.890 |
Why?
|
Receptor, erbB-2 | 7 | 2022 | 2593 | 0.860 |
Why?
|
Agriculture | 1 | 2024 | 186 | 0.820 |
Why?
|
Chagas Disease | 3 | 2020 | 163 | 0.810 |
Why?
|
Nitric Oxide Synthase Type II | 8 | 2020 | 512 | 0.810 |
Why?
|
Atrazine | 1 | 2022 | 9 | 0.800 |
Why?
|
Pesticide Residues | 1 | 2023 | 95 | 0.780 |
Why?
|
Agricultural Workers' Diseases | 1 | 2022 | 27 | 0.780 |
Why?
|
Antioxidants | 9 | 2022 | 1670 | 0.780 |
Why?
|
Proteomics | 9 | 2019 | 3910 | 0.770 |
Why?
|
Reactive Oxygen Species | 12 | 2024 | 2140 | 0.730 |
Why?
|
Leishmania | 5 | 2021 | 75 | 0.720 |
Why?
|
Water Pollutants, Chemical | 1 | 2024 | 358 | 0.690 |
Why?
|
Doxorubicin | 5 | 2021 | 2230 | 0.690 |
Why?
|
Antiprotozoal Agents | 5 | 2019 | 93 | 0.680 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 2 | 2023 | 1106 | 0.680 |
Why?
|
Trypanosoma cruzi | 6 | 2020 | 200 | 0.680 |
Why?
|
Plant Leaves | 1 | 2020 | 154 | 0.670 |
Why?
|
NF-kappa B | 5 | 2024 | 2485 | 0.660 |
Why?
|
Inflammation Mediators | 5 | 2024 | 1884 | 0.660 |
Why?
|
Paclitaxel | 5 | 2021 | 1728 | 0.660 |
Why?
|
Neoplasms | 10 | 2023 | 22340 | 0.610 |
Why?
|
Hospital Records | 1 | 2018 | 93 | 0.590 |
Why?
|
Environmental Monitoring | 1 | 2024 | 1470 | 0.580 |
Why?
|
Cytokines | 13 | 2023 | 7421 | 0.570 |
Why?
|
Interleukin-12 | 4 | 2023 | 579 | 0.560 |
Why?
|
Mass Spectrometry | 5 | 2016 | 2194 | 0.550 |
Why?
|
Peroxidase | 1 | 2020 | 606 | 0.540 |
Why?
|
Antineoplastic Agents, Phytogenic | 3 | 2017 | 616 | 0.530 |
Why?
|
Macrophages, Peritoneal | 5 | 2020 | 243 | 0.530 |
Why?
|
Leishmaniasis, Cutaneous | 4 | 2021 | 137 | 0.530 |
Why?
|
Caffeine | 1 | 2020 | 702 | 0.510 |
Why?
|
Prognosis | 17 | 2024 | 29922 | 0.490 |
Why?
|
Autoimmunity | 2 | 2020 | 1354 | 0.490 |
Why?
|
Lipid Peroxides | 4 | 2023 | 73 | 0.470 |
Why?
|
Pain, Intractable | 1 | 2015 | 132 | 0.470 |
Why?
|
Glutathione | 5 | 2024 | 588 | 0.460 |
Why?
|
Acute-Phase Proteins | 1 | 2015 | 252 | 0.460 |
Why?
|
Mammary Glands, Human | 1 | 2015 | 199 | 0.450 |
Why?
|
Gene Expression Regulation, Neoplastic | 10 | 2023 | 8611 | 0.440 |
Why?
|
Disease Susceptibility | 2 | 2020 | 1789 | 0.430 |
Why?
|
Genital Neoplasms, Female | 1 | 2018 | 533 | 0.410 |
Why?
|
Female | 70 | 2024 | 396112 | 0.400 |
Why?
|
Tumor Microenvironment | 5 | 2023 | 3946 | 0.390 |
Why?
|
Propolis | 3 | 2016 | 15 | 0.390 |
Why?
|
Adiponectin | 2 | 2014 | 1119 | 0.360 |
Why?
|
Down-Regulation | 3 | 2020 | 2927 | 0.350 |
Why?
|
Humans | 80 | 2024 | 765968 | 0.350 |
Why?
|
Metformin | 4 | 2020 | 904 | 0.340 |
Why?
|
Proteome | 3 | 2015 | 1899 | 0.340 |
Why?
|
Chagas Cardiomyopathy | 1 | 2010 | 72 | 0.330 |
Why?
|
Concanavalin A | 2 | 2020 | 191 | 0.330 |
Why?
|
Transforming Growth Factor beta | 3 | 2015 | 1995 | 0.330 |
Why?
|
Drug Resistance, Neoplasm | 6 | 2020 | 5337 | 0.320 |
Why?
|
Lipid Metabolism | 2 | 2017 | 1892 | 0.320 |
Why?
|
Tumor Necrosis Factor-alpha | 7 | 2024 | 4348 | 0.320 |
Why?
|
Models, Cardiovascular | 1 | 2014 | 978 | 0.320 |
Why?
|
Environmental Exposure | 1 | 2024 | 4544 | 0.310 |
Why?
|
Leukotrienes | 1 | 2010 | 232 | 0.310 |
Why?
|
Multiple Myeloma | 2 | 2024 | 5197 | 0.300 |
Why?
|
Leishmania braziliensis | 2 | 2019 | 16 | 0.300 |
Why?
|
Antineoplastic Agents | 8 | 2023 | 13648 | 0.300 |
Why?
|
Anti-Inflammatory Agents | 2 | 2016 | 1808 | 0.290 |
Why?
|
Transforming Growth Factor beta1 | 4 | 2020 | 637 | 0.280 |
Why?
|
Central Nervous System Neoplasms | 1 | 2016 | 916 | 0.280 |
Why?
|
Protein Carbonylation | 4 | 2015 | 27 | 0.280 |
Why?
|
Neutrophils | 1 | 2020 | 3776 | 0.280 |
Why?
|
Chromatography, Liquid | 3 | 2015 | 990 | 0.270 |
Why?
|
Leishmaniasis | 2 | 2017 | 66 | 0.270 |
Why?
|
Breast | 1 | 2015 | 1946 | 0.270 |
Why?
|
Protein Processing, Post-Translational | 1 | 2014 | 1957 | 0.270 |
Why?
|
Middle Aged | 36 | 2024 | 223009 | 0.270 |
Why?
|
Cell Line, Tumor | 14 | 2024 | 17075 | 0.260 |
Why?
|
DNA Damage | 3 | 2017 | 2457 | 0.260 |
Why?
|
Analgesics, Opioid | 1 | 2021 | 3835 | 0.240 |
Why?
|
Carcinoma, Hepatocellular | 3 | 2023 | 2329 | 0.240 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2015 | 2844 | 0.240 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2021 | 9373 | 0.240 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 6 | 2015 | 3807 | 0.240 |
Why?
|
Genetic Predisposition to Disease | 3 | 2021 | 18071 | 0.230 |
Why?
|
Malondialdehyde | 5 | 2015 | 112 | 0.230 |
Why?
|
Ruthenium Compounds | 2 | 2016 | 8 | 0.230 |
Why?
|
Ovarian Neoplasms | 1 | 2021 | 4900 | 0.230 |
Why?
|
Inflammation | 10 | 2024 | 10850 | 0.230 |
Why?
|
Neoplasm Proteins | 2 | 2015 | 3596 | 0.230 |
Why?
|
Adult | 31 | 2024 | 223044 | 0.220 |
Why?
|
NF-E2-Related Factor 2 | 2 | 2024 | 385 | 0.220 |
Why?
|
Antibiotics, Antineoplastic | 2 | 2019 | 679 | 0.220 |
Why?
|
Erythrocytes | 5 | 2015 | 2395 | 0.220 |
Why?
|
Hematocrit | 1 | 2005 | 621 | 0.220 |
Why?
|
Neoplasm Staging | 8 | 2023 | 11206 | 0.210 |
Why?
|
Peroxisome Proliferator-Activated Receptors | 1 | 2023 | 61 | 0.210 |
Why?
|
Wedelia | 1 | 2022 | 1 | 0.210 |
Why?
|
Arthritis, Gouty | 1 | 2022 | 28 | 0.210 |
Why?
|
Aldrin | 1 | 2022 | 2 | 0.200 |
Why?
|
Trifluralin | 1 | 2022 | 2 | 0.200 |
Why?
|
Diuron | 1 | 2022 | 4 | 0.200 |
Why?
|
Chlordan | 1 | 2022 | 5 | 0.200 |
Why?
|
Dieldrin | 1 | 2022 | 7 | 0.200 |
Why?
|
DDT | 1 | 2022 | 33 | 0.200 |
Why?
|
Rats, Wistar | 8 | 2022 | 1884 | 0.200 |
Why?
|
Cell Proliferation | 9 | 2023 | 10429 | 0.200 |
Why?
|
Signal Transduction | 12 | 2024 | 23601 | 0.200 |
Why?
|
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 2022 | 70 | 0.200 |
Why?
|
Interleukin-4 | 2 | 2023 | 1162 | 0.200 |
Why?
|
Epigenesis, Genetic | 2 | 2021 | 3819 | 0.200 |
Why?
|
Mice, Inbred BALB C | 11 | 2021 | 6220 | 0.200 |
Why?
|
Aged | 20 | 2024 | 171117 | 0.200 |
Why?
|
Rural Population | 2 | 2024 | 2317 | 0.200 |
Why?
|
Dichlorodiphenyl Dichloroethylene | 1 | 2022 | 87 | 0.190 |
Why?
|
Liver Neoplasms | 3 | 2023 | 4353 | 0.190 |
Why?
|
Animals | 34 | 2023 | 168764 | 0.190 |
Why?
|
Lung Neoplasms | 3 | 2023 | 13451 | 0.180 |
Why?
|
Chalcone | 1 | 2020 | 10 | 0.180 |
Why?
|
Chalcones | 1 | 2020 | 32 | 0.180 |
Why?
|
Leukocytes, Mononuclear | 2 | 2018 | 1857 | 0.180 |
Why?
|
Medulla Oblongata | 1 | 2022 | 246 | 0.170 |
Why?
|
Research Report | 1 | 2023 | 367 | 0.170 |
Why?
|
Halogenation | 1 | 2020 | 47 | 0.170 |
Why?
|
DNA Modification Methylases | 1 | 2021 | 207 | 0.170 |
Why?
|
Glutathione S-Transferase pi | 1 | 2020 | 99 | 0.170 |
Why?
|
Carcinoma | 1 | 2011 | 2312 | 0.170 |
Why?
|
Perioperative Period | 1 | 2021 | 251 | 0.170 |
Why?
|
STAT3 Transcription Factor | 1 | 2024 | 870 | 0.170 |
Why?
|
Stress, Psychological | 1 | 2015 | 4533 | 0.170 |
Why?
|
Case-Control Studies | 8 | 2024 | 22223 | 0.170 |
Why?
|
Diterpenes | 2 | 2022 | 166 | 0.160 |
Why?
|
Molecular Targeted Therapy | 4 | 2020 | 2822 | 0.160 |
Why?
|
Obesity | 4 | 2017 | 13076 | 0.160 |
Why?
|
Biomarkers, Pharmacological | 1 | 2020 | 162 | 0.160 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 2 | 2016 | 550 | 0.160 |
Why?
|
Proteins | 1 | 2014 | 5995 | 0.160 |
Why?
|
Hypertension | 5 | 2022 | 8626 | 0.160 |
Why?
|
Hematopoietic Stem Cells | 2 | 2024 | 3401 | 0.160 |
Why?
|
Triclosan | 1 | 2019 | 59 | 0.160 |
Why?
|
Leishmania mexicana | 2 | 2015 | 33 | 0.160 |
Why?
|
Sodium Glutamate | 3 | 2017 | 22 | 0.150 |
Why?
|
Ascorbic Acid | 1 | 2022 | 657 | 0.150 |
Why?
|
Quercetin | 1 | 2019 | 97 | 0.150 |
Why?
|
Survival Analysis | 3 | 2024 | 10070 | 0.150 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2024 | 16047 | 0.150 |
Why?
|
Tumor Escape | 1 | 2021 | 371 | 0.150 |
Why?
|
HIV-1 | 2 | 2015 | 6944 | 0.150 |
Why?
|
Apoptosis | 8 | 2023 | 9514 | 0.150 |
Why?
|
Axilla | 1 | 2020 | 615 | 0.140 |
Why?
|
Pharmacogenetics | 1 | 2022 | 682 | 0.140 |
Why?
|
Blotting, Western | 2 | 2015 | 5020 | 0.140 |
Why?
|
Melatonin | 1 | 2023 | 674 | 0.140 |
Why?
|
Superoxide Dismutase | 3 | 2022 | 593 | 0.140 |
Why?
|
Monoterpenes | 1 | 2017 | 21 | 0.140 |
Why?
|
1,2-Dimethylhydrazine | 1 | 2016 | 8 | 0.140 |
Why?
|
Cell Polarity | 1 | 2020 | 636 | 0.140 |
Why?
|
Hematopoietic Stem Cell Mobilization | 1 | 2018 | 227 | 0.140 |
Why?
|
Silver | 1 | 2017 | 120 | 0.140 |
Why?
|
Aberrant Crypt Foci | 1 | 2016 | 12 | 0.140 |
Why?
|
Anti-Infective Agents, Local | 1 | 2019 | 245 | 0.140 |
Why?
|
Tyrosine | 2 | 2024 | 1428 | 0.140 |
Why?
|
Nitroso Compounds | 1 | 2016 | 70 | 0.130 |
Why?
|
Bone Marrow Cells | 1 | 2024 | 2412 | 0.130 |
Why?
|
Early Detection of Cancer | 2 | 2021 | 3236 | 0.130 |
Why?
|
Sympathetic Nervous System | 2 | 2022 | 520 | 0.130 |
Why?
|
Paraneoplastic Polyneuropathy | 1 | 2015 | 2 | 0.130 |
Why?
|
Guanidines | 1 | 2017 | 194 | 0.130 |
Why?
|
Neoplasm Invasiveness | 4 | 2020 | 3602 | 0.130 |
Why?
|
Trypanocidal Agents | 1 | 2016 | 40 | 0.130 |
Why?
|
Lupus Erythematosus, Systemic | 3 | 2013 | 2159 | 0.130 |
Why?
|
Nitrates | 2 | 2015 | 260 | 0.130 |
Why?
|
Immunohistochemistry | 6 | 2016 | 11022 | 0.130 |
Why?
|
Nitroprusside | 1 | 2016 | 271 | 0.130 |
Why?
|
Gout | 1 | 2022 | 620 | 0.120 |
Why?
|
Prostatic Neoplasms | 1 | 2018 | 11083 | 0.120 |
Why?
|
beta Catenin | 1 | 2020 | 1043 | 0.120 |
Why?
|
Uterus | 1 | 2019 | 661 | 0.120 |
Why?
|
Genes, erbB-2 | 1 | 2015 | 160 | 0.120 |
Why?
|
Genetic Heterogeneity | 2 | 2015 | 735 | 0.120 |
Why?
|
Fetal Growth Retardation | 1 | 2019 | 591 | 0.120 |
Why?
|
Monitoring, Immunologic | 1 | 2015 | 99 | 0.120 |
Why?
|
Genomics | 2 | 2022 | 5929 | 0.120 |
Why?
|
Nitric Oxide Donors | 1 | 2015 | 122 | 0.120 |
Why?
|
Catalase | 2 | 2014 | 216 | 0.120 |
Why?
|
Myoblasts, Cardiac | 1 | 2014 | 21 | 0.120 |
Why?
|
Interleukin-1beta | 3 | 2015 | 1028 | 0.120 |
Why?
|
Carcinoma, Ductal | 1 | 2015 | 97 | 0.120 |
Why?
|
Chromatography, High Pressure Liquid | 2 | 2015 | 1526 | 0.120 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2020 | 2942 | 0.120 |
Why?
|
Mice | 17 | 2023 | 81819 | 0.120 |
Why?
|
Brain Neoplasms | 1 | 2016 | 9071 | 0.110 |
Why?
|
Cyclooxygenase 2 | 2 | 2014 | 594 | 0.110 |
Why?
|
Vitamin D | 2 | 2020 | 3272 | 0.110 |
Why?
|
Cyclooxygenase 1 | 1 | 2014 | 98 | 0.110 |
Why?
|
Indomethacin | 1 | 2015 | 322 | 0.110 |
Why?
|
Disease Progression | 3 | 2021 | 13632 | 0.110 |
Why?
|
Interleukin-17 | 1 | 2020 | 921 | 0.110 |
Why?
|
Ferritins | 2 | 2015 | 600 | 0.110 |
Why?
|
Melanoma, Experimental | 1 | 2017 | 558 | 0.110 |
Why?
|
Enzyme Inhibitors | 4 | 2021 | 3715 | 0.110 |
Why?
|
Acute Disease | 2 | 2017 | 7232 | 0.110 |
Why?
|
Gene Expression Profiling | 2 | 2024 | 9525 | 0.110 |
Why?
|
Alleles | 1 | 2024 | 6897 | 0.110 |
Why?
|
Statistics, Nonparametric | 3 | 2013 | 2844 | 0.110 |
Why?
|
Multiple Sclerosis, Chronic Progressive | 1 | 2016 | 253 | 0.110 |
Why?
|
Albumins | 1 | 2016 | 577 | 0.110 |
Why?
|
Metal Nanoparticles | 1 | 2017 | 403 | 0.110 |
Why?
|
Glycerol | 1 | 2014 | 274 | 0.100 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2015 | 633 | 0.100 |
Why?
|
Homocysteine | 1 | 2015 | 638 | 0.100 |
Why?
|
Drug Therapy | 1 | 2015 | 504 | 0.100 |
Why?
|
Immunomodulation | 2 | 2016 | 547 | 0.100 |
Why?
|
Maternal Exposure | 1 | 2019 | 1095 | 0.100 |
Why?
|
Rats | 9 | 2022 | 23707 | 0.100 |
Why?
|
Thiobarbituric Acid Reactive Substances | 1 | 2011 | 45 | 0.100 |
Why?
|
Metabolism, Inborn Errors | 1 | 2014 | 291 | 0.100 |
Why?
|
Oxidants | 1 | 2012 | 166 | 0.090 |
Why?
|
Transcription Factor RelA | 2 | 2024 | 252 | 0.090 |
Why?
|
Glycosylation | 1 | 2014 | 1100 | 0.090 |
Why?
|
Area Under Curve | 1 | 2015 | 1638 | 0.090 |
Why?
|
Paracoccidioidomycosis | 1 | 2011 | 10 | 0.090 |
Why?
|
Genetic Association Studies | 1 | 2021 | 2741 | 0.090 |
Why?
|
Male | 26 | 2024 | 363698 | 0.090 |
Why?
|
HIV Infections | 2 | 2015 | 17533 | 0.090 |
Why?
|
Nitrites | 1 | 2011 | 156 | 0.090 |
Why?
|
Iron | 3 | 2019 | 1816 | 0.090 |
Why?
|
Metabolic Networks and Pathways | 1 | 2015 | 798 | 0.090 |
Why?
|
Heart Rate | 5 | 2022 | 4204 | 0.090 |
Why?
|
Disease-Free Survival | 1 | 2021 | 6832 | 0.090 |
Why?
|
Cell Movement | 2 | 2020 | 5194 | 0.090 |
Why?
|
Skin | 2 | 2016 | 4489 | 0.090 |
Why?
|
In Situ Hybridization | 1 | 2014 | 1886 | 0.090 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2011 | 11868 | 0.090 |
Why?
|
Mice, Knockout | 2 | 2019 | 14448 | 0.090 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2021 | 2880 | 0.080 |
Why?
|
Cardiovascular Diseases | 2 | 2014 | 15652 | 0.080 |
Why?
|
Interferon-gamma | 1 | 2018 | 3160 | 0.080 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2022 | 3655 | 0.080 |
Why?
|
Cytoskeletal Proteins | 1 | 2014 | 1325 | 0.080 |
Why?
|
High-Throughput Screening Assays | 1 | 2014 | 938 | 0.080 |
Why?
|
Th1 Cells | 1 | 2013 | 1039 | 0.080 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2010 | 318 | 0.070 |
Why?
|
Th2 Cells | 1 | 2013 | 1075 | 0.070 |
Why?
|
Prospective Studies | 3 | 2021 | 54802 | 0.070 |
Why?
|
Risk Factors | 4 | 2024 | 74840 | 0.070 |
Why?
|
Cell Adhesion | 1 | 2014 | 3089 | 0.070 |
Why?
|
ROC Curve | 1 | 2015 | 3620 | 0.070 |
Why?
|
Heart Diseases | 1 | 2021 | 2821 | 0.070 |
Why?
|
Hepatitis C, Chronic | 1 | 2015 | 1032 | 0.070 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2012 | 689 | 0.070 |
Why?
|
Parasitemia | 2 | 2020 | 164 | 0.070 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2019 | 2531 | 0.070 |
Why?
|
DNA Methylation | 1 | 2021 | 4424 | 0.070 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2011 | 975 | 0.060 |
Why?
|
Homeostasis | 2 | 2015 | 3336 | 0.060 |
Why?
|
Endotoxemia | 1 | 2007 | 198 | 0.060 |
Why?
|
Cell Survival | 4 | 2017 | 5747 | 0.060 |
Why?
|
Immunotherapy | 1 | 2021 | 4752 | 0.060 |
Why?
|
Antifungal Agents | 1 | 2011 | 769 | 0.060 |
Why?
|
Aspirin | 2 | 2014 | 3134 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-akt | 3 | 2023 | 2453 | 0.060 |
Why?
|
Mass Screening | 1 | 2021 | 5446 | 0.060 |
Why?
|
Genotype | 1 | 2020 | 13024 | 0.060 |
Why?
|
Diet | 1 | 2023 | 8086 | 0.060 |
Why?
|
Osmotic Pressure | 1 | 2005 | 136 | 0.060 |
Why?
|
Pulmonary Edema | 1 | 2007 | 412 | 0.060 |
Why?
|
Nitric Oxide Synthase | 1 | 2007 | 911 | 0.060 |
Why?
|
Myocardium | 3 | 2017 | 4760 | 0.060 |
Why?
|
Autonomic Nervous System | 2 | 2022 | 706 | 0.060 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 8041 | 0.060 |
Why?
|
Blood Pressure | 4 | 2022 | 8532 | 0.060 |
Why?
|
gamma-Glutamyltransferase | 2 | 2015 | 140 | 0.060 |
Why?
|
Overweight | 1 | 2015 | 2444 | 0.060 |
Why?
|
Autophagy | 2 | 2022 | 1351 | 0.050 |
Why?
|
Cohort Studies | 3 | 2015 | 41649 | 0.050 |
Why?
|
Bone Neoplasms | 1 | 2015 | 2567 | 0.050 |
Why?
|
Postmenopause | 1 | 2012 | 2515 | 0.050 |
Why?
|
Cell Size | 1 | 2005 | 625 | 0.050 |
Why?
|
Macrophages | 4 | 2021 | 5772 | 0.050 |
Why?
|
Disabled Persons | 1 | 2012 | 1208 | 0.050 |
Why?
|
Carrier Proteins | 1 | 2015 | 4913 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 1 | 2013 | 6499 | 0.050 |
Why?
|
Bone Marrow | 1 | 2012 | 2921 | 0.050 |
Why?
|
Thiohydantoins | 1 | 2022 | 19 | 0.050 |
Why?
|
Lactates | 1 | 2023 | 398 | 0.050 |
Why?
|
Computer Simulation | 1 | 2015 | 6255 | 0.050 |
Why?
|
Endothelium, Vascular | 1 | 2014 | 4427 | 0.050 |
Why?
|
Piperazines | 1 | 2012 | 2549 | 0.050 |
Why?
|
Fishes | 1 | 2005 | 606 | 0.050 |
Why?
|
Receptors, Estrogen | 3 | 2015 | 2242 | 0.050 |
Why?
|
Risk Assessment | 1 | 2023 | 24282 | 0.050 |
Why?
|
Arginase | 1 | 2021 | 81 | 0.050 |
Why?
|
Dinoprostone | 2 | 2017 | 591 | 0.050 |
Why?
|
Sheep | 1 | 2023 | 1440 | 0.050 |
Why?
|
Body Mass Index | 2 | 2015 | 13039 | 0.040 |
Why?
|
Up-Regulation | 2 | 2020 | 4137 | 0.040 |
Why?
|
Histocompatibility Antigens | 1 | 2021 | 477 | 0.040 |
Why?
|
Heart | 2 | 2010 | 4414 | 0.040 |
Why?
|
Chronic Disease | 1 | 2015 | 9347 | 0.040 |
Why?
|
Pyrimidines | 1 | 2012 | 3047 | 0.040 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2023 | 2878 | 0.040 |
Why?
|
Ganglia, Spinal | 1 | 2022 | 529 | 0.040 |
Why?
|
Cells, Cultured | 4 | 2018 | 18973 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2016 | 15398 | 0.040 |
Why?
|
Young Adult | 3 | 2018 | 59889 | 0.040 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2021 | 440 | 0.040 |
Why?
|
Incidence | 1 | 2018 | 21480 | 0.040 |
Why?
|
Cyclin D1 | 1 | 2021 | 449 | 0.040 |
Why?
|
Estrous Cycle | 1 | 2019 | 62 | 0.040 |
Why?
|
Disease Models, Animal | 4 | 2014 | 18293 | 0.040 |
Why?
|
Insulin Resistance | 1 | 2013 | 3985 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 2021 | 576 | 0.040 |
Why?
|
Major Histocompatibility Complex | 1 | 2021 | 879 | 0.040 |
Why?
|
Melanoma | 1 | 2017 | 5719 | 0.040 |
Why?
|
Acetylation | 1 | 2021 | 1053 | 0.040 |
Why?
|
Anti-HIV Agents | 1 | 2014 | 4559 | 0.040 |
Why?
|
Liver | 4 | 2015 | 7562 | 0.040 |
Why?
|
Leukapheresis | 1 | 2018 | 150 | 0.040 |
Why?
|
Motor Activity | 1 | 2007 | 2704 | 0.040 |
Why?
|
Estrogen Receptor alpha | 1 | 2021 | 578 | 0.040 |
Why?
|
Uric Acid | 2 | 2014 | 809 | 0.030 |
Why?
|
Lactation | 1 | 2019 | 391 | 0.030 |
Why?
|
Phagocytes | 1 | 2018 | 292 | 0.030 |
Why?
|
Colorectal Neoplasms | 1 | 2016 | 6942 | 0.030 |
Why?
|
Phenotype | 1 | 2014 | 16721 | 0.030 |
Why?
|
Heme Oxygenase-1 | 1 | 2019 | 364 | 0.030 |
Why?
|
Nitrosation | 1 | 2016 | 25 | 0.030 |
Why?
|
Aged, 80 and over | 2 | 2020 | 59489 | 0.030 |
Why?
|
Thyroid Hormones | 1 | 2019 | 410 | 0.030 |
Why?
|
Stress, Physiological | 1 | 2023 | 1402 | 0.030 |
Why?
|
Mutation | 1 | 2020 | 30198 | 0.030 |
Why?
|
Cell Membrane | 1 | 2005 | 3634 | 0.030 |
Why?
|
Meglumine | 1 | 2015 | 143 | 0.030 |
Why?
|
NIH 3T3 Cells | 1 | 2017 | 651 | 0.030 |
Why?
|
Interferon-alpha | 1 | 2019 | 910 | 0.030 |
Why?
|
Injections, Intraperitoneal | 1 | 2015 | 413 | 0.030 |
Why?
|
Cardiovascular System | 1 | 2022 | 841 | 0.030 |
Why?
|
Transforming Growth Factor alpha | 1 | 2014 | 134 | 0.030 |
Why?
|
Aspartate Aminotransferases | 1 | 2015 | 415 | 0.030 |
Why?
|
Mice, Inbred C57BL | 3 | 2021 | 22332 | 0.030 |
Why?
|
Time Factors | 1 | 2015 | 40065 | 0.030 |
Why?
|
Erythrocyte Count | 1 | 2014 | 158 | 0.030 |
Why?
|
Anemia | 2 | 2015 | 1511 | 0.030 |
Why?
|
Fetal Development | 1 | 2019 | 777 | 0.030 |
Why?
|
NG-Nitroarginine Methyl Ester | 1 | 2014 | 261 | 0.030 |
Why?
|
Sulfhydryl Compounds | 1 | 2015 | 296 | 0.030 |
Why?
|
Interleukin-10 | 1 | 2019 | 1183 | 0.030 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2016 | 595 | 0.030 |
Why?
|
Hindlimb | 1 | 2015 | 510 | 0.030 |
Why?
|
Alanine Transaminase | 1 | 2015 | 607 | 0.030 |
Why?
|
Dinoprost | 1 | 2013 | 139 | 0.030 |
Why?
|
Sulfonamides | 2 | 2014 | 1984 | 0.030 |
Why?
|
Immunologic Factors | 1 | 2021 | 1587 | 0.030 |
Why?
|
Immunity, Cellular | 1 | 2018 | 1555 | 0.030 |
Why?
|
Lung | 3 | 2022 | 10033 | 0.020 |
Why?
|
Organometallic Compounds | 1 | 2015 | 644 | 0.020 |
Why?
|
Luminescence | 1 | 2012 | 110 | 0.020 |
Why?
|
Mediator Complex | 1 | 2012 | 106 | 0.020 |
Why?
|
Pyrazoles | 2 | 2014 | 2033 | 0.020 |
Why?
|
Paracoccidioides | 1 | 2011 | 3 | 0.020 |
Why?
|
C-Reactive Protein | 2 | 2015 | 3850 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 2015 | 12056 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2023 | 3430 | 0.020 |
Why?
|
Neoplasms, Experimental | 1 | 2016 | 1229 | 0.020 |
Why?
|
Rodent Diseases | 1 | 2011 | 53 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2015 | 1599 | 0.020 |
Why?
|
Logistic Models | 2 | 2016 | 13266 | 0.020 |
Why?
|
Drug Synergism | 1 | 2015 | 1749 | 0.020 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2014 | 707 | 0.020 |
Why?
|
X-Rays | 1 | 2011 | 310 | 0.020 |
Why?
|
Phagocytosis | 1 | 2016 | 1520 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2016 | 3586 | 0.020 |
Why?
|
Colony Count, Microbial | 1 | 2011 | 326 | 0.020 |
Why?
|
Histocytochemistry | 1 | 2011 | 696 | 0.020 |
Why?
|
Tumor Burden | 1 | 2015 | 1885 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2021 | 5786 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2020 | 4893 | 0.020 |
Why?
|
Gene Silencing | 1 | 2015 | 1505 | 0.020 |
Why?
|
Fluorescence | 1 | 2011 | 753 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2022 | 26318 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2022 | 3800 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2014 | 1333 | 0.020 |
Why?
|
Cell Cycle | 1 | 2017 | 2920 | 0.020 |
Why?
|
Hydrogen Peroxide | 1 | 2012 | 743 | 0.020 |
Why?
|
Anthropometry | 1 | 2013 | 1338 | 0.020 |
Why?
|
Models, Statistical | 1 | 2022 | 5089 | 0.020 |
Why?
|
Hemoglobins | 1 | 2014 | 1530 | 0.020 |
Why?
|
Comorbidity | 1 | 2022 | 10563 | 0.020 |
Why?
|
Blood | 1 | 2010 | 597 | 0.020 |
Why?
|
Pain | 1 | 2022 | 5077 | 0.020 |
Why?
|
Follow-Up Studies | 3 | 2014 | 39193 | 0.020 |
Why?
|
Receptors, Progesterone | 1 | 2012 | 1153 | 0.020 |
Why?
|
Administration, Oral | 1 | 2015 | 4015 | 0.020 |
Why?
|
Nitric Oxide Synthase Type I | 1 | 2007 | 171 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2021 | 5783 | 0.020 |
Why?
|
RNA-Binding Proteins | 1 | 2015 | 1874 | 0.020 |
Why?
|
Collagen | 1 | 2015 | 2618 | 0.020 |
Why?
|
Benzamides | 1 | 2012 | 1377 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2015 | 3421 | 0.020 |
Why?
|
Swimming | 1 | 2007 | 212 | 0.020 |
Why?
|
Vitamin D Deficiency | 1 | 2015 | 1348 | 0.020 |
Why?
|
Disability Evaluation | 1 | 2012 | 1820 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2015 | 6309 | 0.010 |
Why?
|
Fibroblasts | 1 | 2015 | 4159 | 0.010 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 2268 | 0.010 |
Why?
|
Wound Healing | 1 | 2015 | 2792 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2012 | 2423 | 0.010 |
Why?
|
Hospitalization | 1 | 2022 | 10808 | 0.010 |
Why?
|
Pandemics | 1 | 2022 | 8703 | 0.010 |
Why?
|
Treatment Outcome | 3 | 2016 | 65188 | 0.010 |
Why?
|
Organ Size | 1 | 2007 | 2260 | 0.010 |
Why?
|
Adrenal Cortex Hormones | 1 | 2011 | 1880 | 0.010 |
Why?
|
Immunity, Innate | 1 | 2014 | 3081 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2014 | 10729 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2016 | 12976 | 0.010 |
Why?
|
Cell Line | 1 | 2014 | 15543 | 0.010 |
Why?
|
Survival Rate | 1 | 2014 | 12795 | 0.010 |
Why?
|
Lipopolysaccharides | 1 | 2007 | 2216 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2018 | 5753 | 0.010 |
Why?
|
Insulin | 1 | 2013 | 6599 | 0.010 |
Why?
|
Blood Glucose | 1 | 2013 | 6424 | 0.010 |
Why?
|
Sex Factors | 1 | 2013 | 10603 | 0.010 |
Why?
|
Public Health | 1 | 2011 | 2680 | 0.010 |
Why?
|
Adipose Tissue | 1 | 2010 | 3312 | 0.010 |
Why?
|
Pregnancy | 1 | 2019 | 30260 | 0.010 |
Why?
|
Body Weight | 1 | 2007 | 4622 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2018 | 81514 | 0.010 |
Why?
|
Age Factors | 1 | 2013 | 18380 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2012 | 5696 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2012 | 15880 | 0.010 |
Why?
|